● Инвестиционный фонд Global Infrastructure Partners согласился купить компанию Equis Energy, сингапурского разработчика проектов в области возобновляемых источников энергии, за рекордные для отрасли $5 млрд, пишет Bloomberg.
● Dow Jones достиг рекорда. Индекс Dow Jones industrial average резко вырос во вторник на фоне сильных квартальных результатов компаний 3M и Caterpillar, сообщает CNBC.
● Американский фонд прямых инвестиций Cerberus Capital Management выразил заинтересованность в покупке Alitalia, испытывающей финансовые проблемы. Cerberus хочет, чтобы Alitalia осталась независимой авиакомпанией. Но ранее свои предложения уже сделали EasyJet и Lufthansa
Gapping down
In reaction to disappointing earnings/guidance:
- ACHC -22.3%, AMD -10.7%, CMG -10.6%, MANH -9.9%, GHM -8.5%, JNPR -6.7%, EW -6.3%, VICR -6.3%, DPS -5.1%, SFLY -3.6%, NBR -3.4%, EXP -3.3%, DFS -3.1%, WYN -2.3%, AMX -2.1%, T -2%, TXN -1.7%, OC -1.6%, ESRX -1.4%, ROL -1.1%
Other news:
- SNSS -13.5% (commences offering of common stock and Series D Convertible Preferred Stock)
- SVRA -11% (commences common stock offering; size not disclosed; anounces its indication expansion strategy of its lead product candidate Molgradex for the treatment of nontuberculous mycobacterial lung infection; plans to initiate a Phase 2a multi-center clinical trial in subjects with antibiotic-resistant NTM lung infection in early 2018)
- HCM -9.4% (to offer $262.0 million of ADS’s, each representing one-half of one ordinary share )
- IDRA -8.7% ( commences $60 mln common stock offering)
- SALT -7.8% (commences 10 mln common stock offering )
- BIOA -6.5% (accepted the resignation of Pres/COO Fabrice Orecchioni; will be assuming advisory role through to February 24, 2018)
- SACH -6% (prices 3.75 mln common stock offering at $4.00/share)
- PFLT -4.5% (to make a public offering of 6,000,000 shares of its common stock )
- ATNM -4.1% ( indicated lower after filing for $200 mln mixed securities shelf offering and $75 mln ATM under 424B3)
- IMDZ -1.1% (prices 18.5 mln shares of common stock at $4.10 per share)
- NVDA -0.5% (following AMD results)
Analyst comments:
- RCII -5.3% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- PII -1.7% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- GM -1.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- HBI -1% (downgraded to Market Perform from Outperform at Wells Fargo)
- NVS -0.5% (downgraded to Underweight from Equal Weight at Barclays)
Gapping up
In reaction to strong earnings/guidance:
- APOP +25.4%, CAPR +18.6%, AKAM +8.5%, MDCO +8.1%, IRBT +5.6%, USNA +4.5%, WBA +4.4%, MKSI +4.3%, KRA +4.1%, LPL +4.1%, RES +3.5%, RGC +3.4%, BTI +3.1%, (provides update to outlook at its Capital Markets Day), TUP +3%, NOC +2.9%,TSS +2.7%, OFG +2.5%, FLIR +2.5%, AMED +2.4%, WB +2.3%, (also commences $700 mln offering of convertible senior notes due 2022 ), ILMN +2%, COF +1.9%, LYG +1.7%, HES +1.7%, SIX +1.5%, VNOM +1.4%, BXMT +1.4%, SIRI +1.4%, AVY +1.1%,CNI +1%, NUVA +1%, CEO +0.8%, AOS +0.8%, BAX +0.6%
M&A news:
- S +1.4% (T-Mobile US and Sprint (S) are preparing Boards for merger decision, according to Reuters)
Other news:
- BONT +21.2% (after closing near highs on credit facility update)
- OSTK +4.4% (extending today’s move higher after confirming key details on tZERO’s ICO at Money 20/20 )
- LL +4.4% (disclosed memorandum of understanding to settle class actions related to Chinese-Laminate flooring )
- SENS +3.3% (continued strength)
- ANTM +2.8% (announces that the Co has successfully activated fifteen clinical trial sites in the pivotal Phase 3 SIERRA trial for Iomab-B)
- MZOR +2.3% (reports 379-Patient controlled study also reveals seven-fold reduction in revision surgery)
- AMC +1.4% (following RGC results)
- TNDM +1.1% (to make any new features approved for the t:slim X2 Insulin Pump by the FDA in 2018 available to all in-warranty users at no cost through the Tandem Device Updater )
- VRAY +0.9% (raised approx $50 mln through offering)
Analyst comments:
- ALDX +4.8% (initiated with a Overweight at Cantor Fitzgerald)
- ILMN +2% (upgraded to Outperform at Robert W. Baird)
- LDOS +1.4% (upgraded to Outperform from Market Perform at Wells Fargo)
- UAL +1% (upgraded to Outperform at Evercore ISI)